As of 2025-05-16, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is 159.97 USD. This relative valuation is based on P/E multiples. With the latest stock price at 106.07 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is 50.8%.
The range of the Relative Valuation is 103.17 - 294.81 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 37.7x | 27.2x |
| Forward P/E multiples | 21.7x - 28.8x | 22.5x |
| Fair Price | 103.17 - 294.81 | 159.97 |
| Upside | -2.7% - 177.9% | 50.8% |
| Date | P/E |
| 2025-05-16 | 13.78 |
| 2025-05-15 | 13.56 |
| 2025-05-14 | 13.62 |
| 2025-05-13 | 13.15 |
| 2025-05-12 | 13.24 |
| 2025-05-09 | 12.50 |
| 2025-05-08 | 12.58 |
| 2025-05-07 | 12.97 |
| 2025-05-06 | 14.21 |
| 2025-05-05 | 15.11 |
| 2025-05-02 | 15.34 |
| 2025-05-01 | 14.98 |
| 2025-04-30 | 14.95 |
| 2025-04-29 | 14.88 |
| 2025-04-28 | 14.43 |
| 2025-04-25 | 14.16 |
| 2025-04-24 | 13.93 |
| 2025-04-23 | 13.32 |
| 2025-04-22 | 13.21 |
| 2025-04-21 | 12.82 |
| 2025-04-17 | 13.14 |
| 2025-04-16 | 12.98 |
| 2025-04-15 | 13.15 |
| 2025-04-14 | 13.00 |
| 2025-04-11 | 12.84 |
| 2025-04-10 | 13.04 |
| 2025-04-09 | 14.07 |
| 2025-04-08 | 13.14 |
| 2025-04-07 | 13.67 |
| 2025-04-04 | 14.06 |
| 2025-04-03 | 15.44 |
| 2025-04-02 | 16.16 |
| 2025-04-01 | 15.98 |
| 2025-03-31 | 15.87 |
| 2025-03-28 | 15.71 |
| 2025-03-27 | 16.16 |
| 2025-03-26 | 16.73 |
| 2025-03-25 | 17.29 |
| 2025-03-24 | 18.15 |
| 2025-03-21 | 17.74 |
| 2025-03-20 | 17.97 |
| 2025-03-19 | 18.16 |
| 2025-03-18 | 17.83 |
| 2025-03-17 | 17.92 |
| 2025-03-14 | 17.63 |
| 2025-03-13 | 17.39 |
| 2025-03-12 | 17.15 |
| 2025-03-11 | 17.49 |
| 2025-03-10 | 17.57 |
| 2025-03-07 | 17.74 |